Increased copy number of SPRY4 may contribute to the increased expression observed in this study, and was therefore investigated in CRC patient adenocarcinomas classified as SPRY4-diploid compared against patients with copy number gains of SPRY4. The gene discussed is SPRY4; the disease is adenocarcinoma.